| Attribute | Number of subjects | ||||
|---|---|---|---|---|---|
| Gender | Female | 13843/26045 (53.15%) | |||
| Male | 12199/26045 (46.84%) | ||||
| Undeterminated | 3/26045 (0.01%) | ||||
| Subject Status | Followed | 24426/26045 (93.78%) | |||
| Lost to Follow-up | 1331/26045 (5.11%) | ||||
| Opted out | 288/26045 (1.11%) | ||||
| Registry | JIA Utrecht | 190/26045 (0.73%) | |||
| Pharmachild | 9000/26045 (34.56%) | ||||
| ESID | 12770/26045 (49.03%) | ||||
| Eurofever | 4085/26045 (15.68%) | ||||
| Consent contact | 26022/26045 (99.91%) | ||||
| Consent reuse | 13273/26045 (50.96%) | ||||
| Biobank sample | 1520/26045 (5.84%) | Onset age | Diagnosis age | First contact age | Death age |
| Mean | 8.6 | 11.86 | 9.89 | 17.72 | |
| Standard deviation | 12.63 | 14.77 | 13.13 | 16.2 | |
| First Quartile | 1 | 3 | 2 | - | |
| Median | 4 | 7 | 5 | - | |
| Third Quartile | 11 | 14 | 12 | - | |
| Min | 0 | 0 | 0 | 0 | |
| Max | 81 | 82 | 81 | 68 | |